HC
HCAT.US Health Catalyst Inc
- Market cap
- USD 115M
- P/E
- -
- P/B
- 0.79x
- ROE
- -101.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is HCAT.US undervalued?
Graham numberThe Graham number of Health Catalyst Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Health Catalyst Inc fundamental analysis
No fundamental analysis for Health Catalyst Inc yet.
Health Catalyst Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Health Catalyst Inc
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face acros…
Full company profileHealth Catalyst Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Health Catalyst Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 73.1M | 113M | 155M | 189M | 242M | 276M | 296M | 307M | 311M | 263M |
| Gross Profit | 29.4M | 52.7M | 79.6M | 90.8M | 118M | 133M | 132M | 141M | 104M | 110M |
| Operating Income | -45.5M | -60.1M | -54.9M | -96.1M | -144M | -140M | -127M | -69.8M | -36.1M | -78.6M |
| EBITDA | -39.7M | -52.1M | -47.3M | -85.9M | -105M | -86.1M | -68.3M | -10.7M | -110M | -96.8M |
| Net Income | -47.0M | -62.0M | -60.1M | -115M | -153M | -137M | -118M | -69.5M | -178M | -148M |
| EPS | -1.69 | -2.23 | -3.21 | -2.91 | -3.23 | -2.54 | -2.09 | -1.15 | -2.55 | -1.95 |
| Balance Sheet | ||||||||||
| Total Assets | 110M | 111M | 302M | 578M | 832M | 752M | 702M | 859M | 503M | 237M |
| Total Liabilities | 370M | 486M | 102M | 302M | 310M | 327M | 335M | 494M | 257M | 91.8M |
| Shareholders' Equity | -259M | -375M | 201M | 276M | 522M | 425M | 367M | 365M | 246M | 146M |
| Cash & Short-term Investments | 51.5M | 33.2M | 228M | 271M | 445M | 363M | 318M | 392M | 95.7M | 79.0M |
| Total Debt | 12.6M | 26.9M | 52.7M | 195M | 205M | 248M | 249M | 402M | 171M | 15.8M |
| Cash Flow | ||||||||||
| Operating Cash Flow | -36.8M | -40.3M | -32.2M | -26.1M | -23.1M | -35.3M | -33.1M | 14.6M | 731K | 22.5M |
| Capital Expenditure | 3.34M | 2.50M | 4.33M | 10.5M | 18.5M | 17.4M | 14.3M | 16.4M | 968K | 25.8M |
| Free Cash Flow | -40.2M | -42.8M | -36.5M | -36.6M | -41.6M | -52.7M | -47.4M | -1.84M | -237K | 21.4M |
| Ratios | ||||||||||
| ROE | - | - | -30.0% | -41.7% | -29.3% | -32.3% | -32.2% | -19.0% | -72.4% | -101.7% |
| ROA | -42.7% | -55.9% | -19.9% | -19.9% | -18.4% | -18.3% | -16.8% | -8.1% | -35.4% | -62.4% |
| Net Profit Margin | -64.4% | -55.1% | -38.8% | -60.9% | -63.3% | -49.7% | -39.9% | -22.7% | -57.2% | -56.2% |
| Debt to Equity | - | - | 0.26x | 0.71x | 0.39x | 0.58x | 0.68x | 1.10x | 0.70x | 0.11x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Health Catalyst Inc dividends
Health Catalyst Inc has not paid dividends in the last 9 fiscal years.
Who owns Health Catalyst Inc
- Insiders 9.46%
- Institutions 69.69%
- Public & others 20.85%
- Shares outstanding 76.2M
- Free float 60.2M
Top funds holding HCAT.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Impax Small Cap Institutional | 4.00M | 5.25% | 0.00% | Sep 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 2.06M | 2.70% | 0.00% | Sep 2026 |
| Fidelity Enhanced Small Cap Core ETF | 484K | 0.64% | +0.27% | Oct 2026 |
| Schwab US Small-Cap ETF™ | 328K | 0.43% | +0.23% | Oct 2026 |
| Fidelity Extended Market Index | 293K | 0.39% | +13.67% | Sep 2026 |
| iShares Micro-Cap ETF | 174K | 0.23% | 0.00% | Oct 2026 |
| Schwab Total Stock Market Index | 158K | 0.21% | 0.00% | Sep 2026 |
| Vanguard Health Care ETF | 138K | 0.18% | +0.11% | Sep 2026 |
| Fidelity Total Market Index | 132K | 0.17% | -0.05% | Sep 2026 |
| Fidelity Series Total Market Index | 117K | 0.15% | 0.00% | Sep 2026 |
| Schwab US Broad Market ETF | 111K | 0.15% | +0.08% | Oct 2026 |
| EA Bridgeway Ultra-Small Company Mkt ETF | 78.4K | 0.10% | 0.00% | Oct 2026 |
| Harbor Health Care ETF | 63.8K | 0.08% | 0.00% | Oct 2026 |
| WisdomTree US SmallCap Earnings ETF | 57.9K | 0.08% | 0.00% | Oct 2026 |
| Goldman Sachs Absolute Ret Trckr Instl | 43.5K | 0.06% | +305.60% | Jun 2026 |
| Fidelity ZERO Total Market Index | 39.9K | 0.05% | 0.00% | Sep 2026 |
| Fidelity ZERO Extended Market Index | 39.8K | 0.05% | +840.26% | Sep 2026 |
| Vanguard MStar Inst Ttl StkMktIdxInstlPl | 37.1K | 0.05% | 0.00% | Sep 2026 |
| Invesco RAFI US 1500 Small-Mid ETF | 36.2K | 0.05% | 0.00% | Oct 2026 |
| Vanguard Balanced Index Inv | 35.9K | 0.05% | 0.00% | Sep 2026 |
Top institutions holding HCAT.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| First Light Asset Management, LLC | 12.8M | 16.82% | -0.53% | Jun 2026 |
| Palogic Value Management LP | 9.84M | 12.93% | +239.88% | Jun 2026 |
| CDC Financial, Inc. | 7.09M | 9.31% | +12.46% | Jun 2026 |
| Impax Asset Management Group PLC | 4.00M | 5.25% | 0.00% | Sep 2026 |
| Nepsis, Inc. | 2.99M | 3.93% | +0.45% | Sep 2026 |
| Vanguard Capital Management, LLC | 2.97M | 3.90% | +2.98% | Jun 2026 |
| BlackRock Inc | 1.84M | 2.41% | -64.26% | Jun 2026 |
| Acadian Asset Management LLC | 1.05M | 1.38% | +630.65% | Sep 2026 |
| Jane Street Group LLC | 1.04M | 1.36% | +3,806.14% | Jun 2026 |
| Geode Capital Management, LLC | 891K | 1.17% | -40.63% | Jun 2026 |
| Caption Management, LLC | 774K | 1.02% | +0.23% | Jun 2026 |
| Mink Brook Asset Management LLC | 738K | 0.97% | 0.00% | Jun 2026 |
| Prescott Group Capital Management LLC | 711K | 0.93% | 0.00% | Jun 2026 |
| Charles Schwab Investment Management Inc | 616K | 0.81% | +1.42% | Jun 2026 |
| HRT FINANCIAL LLC | 572K | 0.75% | +135.29% | Jun 2026 |
| Millennium Management LLC | 516K | 0.68% | 0.00% | Jun 2026 |
| The Goldman Sachs Group Inc | 481K | 0.63% | +24.23% | Jun 2026 |
| Vanguard Fiduciary Trust Co | 463K | 0.61% | +4.36% | Jun 2026 |
| Citadel Advisors Llc | 453K | 0.60% | 0.00% | Jun 2026 |
| Susquehanna International Group, LLP | 437K | 0.57% | +438.76% | Jun 2026 |
Health Catalyst Inc company profile
- Company name
- Health Catalyst Inc
- Ticker
- HCAT.US
- Exchange
- USA Stocks
- Listed since
- Jul 25, 2019
- Sector
- Healthcare
- Industry
- Health Care Technology
- Employees
- 1,200
- Fiscal year end
- December
- Address
- 10897 South River Front Parkway, South Jordan, UT, United States, 84095
- Phone
- 801 708 6800
- Website
- healthcatalyst.com
About Health Catalyst Inc
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics. The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, accountable care organizations, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.
Health Catalyst Inc management
10- Mr. Jason AlgerChief Financial Officer · born 1984
- Mr. Benjamin LandryGeneral Counsel & Secretary of the Board · born 1982
- Mr. Benjamin AlbertChief Business Officer · born 1973
- Mr. Simeon M. KohlCEO, President, Principal Executive & Operating Officer and Director · born 1967
- Ms. Stephanie St. ClairSenior Vice President of Finance & Investor Relations
- Mr. Kyle J. SalyersChief Strategy Officer & Senior VP of Corporate Development
- Ms. Carrie Kozlowski OTChief Marketing Officer
- Becky VeaChief Human Resources Officer
- Mr. Jeffrey P. SelanderSenior Vice President of International
- Ms. Holly RimmaschSenior VP & Chief Clinical Officer